Library

Home > Library

Search results : global financial cycle

Global Macro Fundamental Industry Analysis 2.0 (March 2026)

2026-03-14This ebook delves into the fundamental analysis of new competitive advantages in many global macro industries.

Our fintech finbuzz analytic report shines light on the current global macro outlook. As of Spring-Summer 2026, we delve into the mainstream fundamental analysis of each of the mainstream global macro markets, sectors, and indu...+See More
AYA macro tech ebook on the fundamental analysis of each of the mainstream global macro markets, sectors, and industries September 2025

2025-09-11This ebook delves into the fundamental analysis of new competitive advantages in many global macro industries.

Our fintech finbuzz analytic report shines light on the current global macro-financial outlook. As of Summer-Fall 2025, we delve into the fundamental analysis of global macro industries in terms of competitive advantages, techn...+See More
AYA macro ebook on the fundamental analysis of the global financial system March 2025

2025-03-03This new ebook delves into the fundamental analysis of competitive advantages in the global financial system.

Our fintech finbuzz analytic report shines light on the current global macro-financial outlook. As of Summer-Fall 2025, we delve into the fundamental analysis of core competitive advantages in the global financial system. In th...+See More
1

Blog+More

Goldman Sachs follows the timeless business principles and best practices in financial market design and investment management.

Chanel Holden

2020-02-26 09:30:00 Wednesday ET

Goldman Sachs follows the timeless business principles and best practices in financial market design and investment management.

Goldman Sachs follows the timeless business principles and best practices in financial market design and investment management. William Cohan (2011) M

+See More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More

AYA finbuzz podcast offers fresh insights into the latest stock market issues and economic trends for better and wiser investment decisions.

Amy Hamilton

2019-06-30 12:37:00 Sunday ET

AYA finbuzz podcast offers fresh insights into the latest stock market issues and economic trends for better and wiser investment decisions.

AYA Analytica finbuzz podcast channel on YouTube June 2019 In this podcast, we discuss several topical issues as of June 2019: (1) Federal Reserve h

+See More

Former New York Times team journalist and Pulitzer Prize winner Charles Duhigg delves into how we can change our lives for the better by mastering our habits from day to day.

Monica McNeil

2025-06-05 00:00:00 Thursday ET

Former New York Times team journalist and Pulitzer Prize winner Charles Duhigg delves into how we can change our lives for the better by mastering our habits from day to day.

Former New York Times team journalist and Pulitzer Prize winner Charles Duhigg describes, discusses, and delves into how we can change our respective lives

+See More

President Trump introduces $50 billion tariffs on Chinese products and new limits on Chinese high-tech investments in America.

Apple Boston

2018-05-25 07:30:00 Friday ET

President Trump introduces $50 billion tariffs on Chinese products and new limits on Chinese high-tech investments in America.

President Trump introduces $50 billion tariffs on Chinese products and new limits on Chinese high-tech investments in America. This new round of tariffs

+See More

Many successful business organizations develop their distinctive capabilities and unique value propositions for strategic reasons.

Jacob Miramar

2020-09-17 12:28:00 Thursday ET

Many successful business organizations develop their distinctive capabilities and unique value propositions for strategic reasons.

Many successful business organizations develop their distinctive capabilities and unique value propositions for strategic reasons. Paul Leinwand and Cesa

+See More